Research Groups and R&D Platforms: Target discovery
Research Group:
PET imaging of neuropathological changes in animal models of Alzheimer’s disease
Merja Haaparanta-Solin
mehaaso[at]utu.fi
Turku PET Centre, Preclinical Imaging,
University of Turku
Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Cardiovascular diseases, Diabetes, Disease models, Drug target, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Metabolic diseases, Nanoparticles, Neurological disorders, Organic compounds, PET, Pharmacology, Preclinical development, Receptor, Target discovery
Research Group:
Imaging Alzheimer’s disease beta-amyloid pathology in transgenic mouse models using positron emission tomography
Francisco López-Picón
fralop[at]utu.fi
Turku PET Centre, Preclinical Imaging,
University of Turku
Ageing-related diseases, Biomarker, Biomedicine, Biopharmaceuticals, Clinical Medicine, Disease models, Drug delivery, Drug target, Epigenomics, Imaging, Imaging software, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Molecular Biology, Molecular diagnostics, Neurological disorders, Pathology, PET, Pharmacology, Physiology, Preclinical development, Proteomics, Target discovery
Research Group:
Heat Shock Response Goes Beyond Cell Stress
Lea Sistonen
lea.sistonen[at]abo.fi
Department of Biosciences
Åbo Akademi University
Ageing-related diseases, Basic research, Biomarker, Biomedicine, Breast cancer, Cancer, Data mining, Disease models, Epigenomics, Genomics, Imaging, Molecular Biology, Molecular Cell Biology, Neurological disorders, Prostate cancer, Proteomics, Signaling, Target discovery
Research Group:
Leukocyte traffic and the immune response
Marko Salmi
marko.salmi[at]utu.fi
Institute of Biomedicine
University of Turku
Autoimmune diseases, Basic research, Biomarker, Biomedicine, Cancer, Cardiovascular diseases, Imaging, Immunology, Inflammation, Next-generation sequencing, Receptor, Screening, Target discovery
Research Group:
Structural bioinformatics for drug discovery and development
Mark S. Johnson
finmark54 at icloud dot com
Biochemistry,
Åbo Akademi University
Structural Bioinformatics Laboratory
Ageing-related diseases, Autoimmune diseases, Basic research, Biochemistry, Bioinformatics, Biomolecular chemistry, Biopharmaceuticals, Biotechnology, Cancer, Chemical Physics, Computer Science, Diabetes, Drug target, Hit to lead, Inflammation, Inherited diseases, Lead optimization, Lung cancer, Medicinal chemistry, Metabolic diseases, Molecular modelling, Musculoskeletal disorders, Nucleic acids, Organic compounds, Pattern recognition, Personalized medicine, Physico-chemical properties, Preclinical development, Receptor, Signaling, Structural Biology, Surface area, Target discovery, X-ray crystallography
Research Group:
Molecular mechanisms of diseases
Ulla Pentikäinen
ulla.pentikainen[at]utu.fi
Institute of Biomedicine,
University of Turku
Basic research, Bioinformatics, Biomedicine, Biomolecular chemistry, Cancer, Cardiovascular diseases, Developmental disorders, Medicinal chemistry, Molecular modelling, NMR, Structural Biology, Target discovery, X-ray crystallography
